Olando K3-2 vs Other Brands: The Practical Choice for GMP Lines

When selecting a laser tablet drilling system for osmotic tablets (e.g., Metformin, Nifedipine), real-world performance beats brochure numbers.

For a full overview of the certifications and compliance standards our equipment meets, see our Certifications & Compliance page.

---

Why this comparison matters

• More than peak speed: Operators, cleaning/changeover, compliance, and response time drive OEE and time-to-validation.
• GMP realities: Space is tight; digital records must pass audits.

---

Key Differences at a Glance

Dimension	Olando K3-2
Throughput	Up to 120,000 tablets/hour
Compliance	Designed to support 21 CFR Part 11 compliance: access control, audit trail; validation documentation templates available

---

---

Selection guidance

• Audit-led projects: Request Part 11 features (user roles, audit trail) and IQ/OQ templates from any vendor—K3-2 provides both.

---

Engineering highlights (K3-2)

• Vision: inline vision inspection with real-time reject.
• Control: Industrial control system; Siemens PLC.
• Compliance: Designed to support 21 CFR Part 11 compliance (access control, audit trail); validation documentation templates available.

---

Procurement & validation checklist

1. Part 11: user roles, audit trail; sample logs/screenshots.
2. Validation document templates; SOPs and training materials.
3. Cleaning/changeover: dead-spot access, typical time for size/recipe change.
4. MES/EBR connectivity and export formats for traceability.
5. Service SLA: response time, spare parts lead time, preventive maintenance plan.

---

See the machine

Product page: Olando K3-2 Pharmaceutical Laser Drilling System

---

Conclusion

The Olando K3-2 offers up to 120,000 tablets/hour (based on a 15 mm tablet), with dual-station vision inspection and a design that supports 21 CFR Part 11 compliance.

---

Frequently Asked Questions

Q: How does laser drilling create controlled-release tablets?

A: Laser drilling creates a precise aperture in the tablet coating, forming the drug delivery orifice for osmotic pump tablet systems (OROS technology). The osmotic pressure differential between the tablet core and gastrointestinal fluids drives API release through this aperture at a controlled rate. Hole diameter, depth (blind vs. through-hole), and position are critical parameters. The Olando K3-2 offers ±0.1 mm accuracy and up to 120,000 tablets/hour (based on a 15 mm tablet), with closed-loop vision inspection.

Q: Can the Olando K3-2 drill blind holes and through-holes?

A: Yes — the Olando K3-2 offers 0.9 mm blind/through-hole precision with ±0.05 mm hole depth consistency.

Q: What tablet shapes and sizes can the Olando K3-2 process?

A: The Olando K3-2 handles bilayer round tablets. Supported tablet diameters range from 6 mm to 20 mm. The system processes up to 120,000 tablets/hour (based on a 15 mm tablet).

Q: Is the laser drilling system designed to support FDA 21 CFR Part 11 requirements?

A: The Olando K3-2 Laser Drilling System is designed for cGMP environments, uses a Siemens PLC, and is designed to support 21 CFR Part 11 compliance (audit trail, electronic records, access control). For a full Part 11 workflow (final compliance is established by the end user's own validation), integrate the system's data outputs into a validated manufacturing execution system (MES). Reference customers include Shanghai Modern Pharmaceutical (12 installed units for Nifedipine CR) and Shanghai Xinyi Pharmaceutical (3 units for Doxazosin Mesylate).

Q: What are the ongoing maintenance requirements for laser drilling equipment?

A: The Olando K3-2 solution includes validation documentation templates and operator training; on-site validation is carried out by the end user. Build preventive maintenance into your equipment qualification protocol (IQ/OQ/PQ), and confirm the maintenance plan for your line with Huanghai.